When COVID-19 swept across the world, people searched for answers, reliable information and hope. Among the scientists helping the world navigate the crisis was Dr. Soumya Swaminathan, an Indian paediatrician whose decades of medical research had prepared her for a role far beyond the hospital or laboratory.
A Childhood Shaped by Science
Born on 2 May 1959 in Chennai, Soumya grew up in a family where science, education and social responsibility were deeply valued. Her father, Dr. M. S. Swaminathan, was the celebrated agricultural scientist known as the architect of India’s Green Revolution. Her mother, Mina Swaminathan, was an educationist who championed children’s learning and development.
Growing up alongside her two sisters, Madhura and Nitya, Soumya witnessed how knowledge could address real human needs. She chose medicine, studying at the Armed Forces Medical College in Pune before earning her MD in Paediatrics from AIIMS, New Delhi. She later specialised in paediatric pulmonology at the Children’s Hospital Los Angeles in the United States.
Fighting TB and HIV
Rather than limiting herself to clinical practice, Dr. Swaminathan pursued research into tuberculosis (TB) and HIV, two diseases that have disproportionately affected vulnerable communities.
Her work examined how these infections interact, how they can be diagnosed and treated, and how their consequences can be reduced. She spent years combining patient care with clinical and epidemiological research, including leading the National Institute for Research in Tuberculosis in Chennai.
Her findings contributed to national and international guidelines, helping improve approaches to prevention and treatment, particularly where healthcare resources were limited. With more than 480 peer-reviewed publications, she established herself as a leading voice in global infectious-disease research.
Leading Science at WHO
In 2015, she became Director General of the Indian Council of Medical Research (ICMR), India’s premier medical research body. She worked to strengthen research capacity, encourage scientific collaboration and bring evidence into health policy.
In 2017, she joined the World Health Organization as Deputy Director-General for Programmes. In 2019, she became its first Chief Scientist, helping establish the organisation’s Science Division to strengthen research, scientific standards and digital health.
The COVID-19 pandemic tested this leadership on a global scale. She helped coordinate scientific advice and communication as evidence about the virus evolved. She also played a key role in establishing COVAX, the international initiative designed to expand equitable access to COVID-19 vaccines, especially for lower-income countries.
The challenge was not simply developing scientific solutions; it was ensuring that people across countries could benefit from them.
Continuing the Mission
After leaving WHO in 2022, Dr. Swaminathan returned to India. In February 2023, she became Chairperson of the M. S. Swaminathan Research Foundation (MSSRF), continuing her engagement with public health, nutrition and sustainable development. She also serves as Principal Advisor to India’s National Tuberculosis Elimination Programme.
In 2026, she was elected a Fellow of the Royal Society, one of the world’s most distinguished scientific honours. Dr. Swaminathan’s journey shows how science can move from research papers to national policy and global action. Her contribution lies not only in what she discovered, but in how she helped translate scientific evidence into decisions affecting millions of lives.
